• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Int J Infect Dis . Superinfection is associated with short-term outcome and mortality in viral respiratory tract infections during the fall-winter s

tetano

Editor, Senior Moderator
Int J Infect Dis


. 2022 Apr 8;S1201-9712(22)00207-7.
doi: 10.1016/j.ijid.2022.04.008. Online ahead of print.
Superinfection is associated with short-term outcome and mortality in viral respiratory tract infections during the fall-winter seasons 2016-2018 in the Greater Paris area: the SUPERFLUOUS study


Benjamin Davido[SUP] 1 [/SUP], Benoit Lemarie[SUP] 2 [/SUP], Elyanne Gault[SUP] 3 [/SUP], Marion Pepin[SUP] 4 [/SUP], Karim Jaffal[SUP] 2 [/SUP], Sebastien Beaune[SUP] 5 [/SUP], Lotfi Dahmane[SUP] 6 [/SUP], Jennifer Dumoulin[SUP] 7 [/SUP], Segolene Greffe[SUP] 8 [/SUP], Djillali Annane[SUP] 9 [/SUP], Pierre De Truchis[SUP] 2 [/SUP]



Affiliations

Abstract

Background: Following the study of the predictors of superinfection in viral respiratory tract infections (VRTIs), this study analyses the predictors of the outcome.
Methods: Multicenter retrospective study conducted among adults who tested positive for VRTIs with RT-PCR. We compared characteristics between Influenzavirus, Paramyxoviridae and Pneumoviridae and identified predictors of favourable short-term outcome, admission to intensive care unit (ICU) and mortality.
Results: 590 patients had VRTI, including 347 (59%) influenza infections. Mean (SD) patient age was 71.0 (18.3) years, with a sex-ratio of 0.91. In multivariate analyses, predictors of short-term favourable outcome were age≤75 years-old (aOR,5.38 [95% CI,1.59-18.2]), absence of respiratory disease (4.94,[1.01-24.37]) and absence of superinfection (3.91,[1.37-11.13]). The predictors of ICU admission were age≤75 years-old (3.28,[1.71-6.25]), chronic respiratory disease (2.49,[1.20-5.19]) and procalcitonin level >0.25ng/mL (4.25,[1.55-11.67]). Predictors of mortality were use of inhaled corticosteroids (2.49,[1.10-5.63]), influenza infection (2.73,[1.27-5.85]), Charlson score ≥5 (5.35,[1.90-15.05]), superinfection (2.54,[1.05-6.18]) and eosinophil count <50/µL (4.39,[1.19-16.2]). Certainty of superinfection was significantly associated with mortality (2.23,[1.15-4.3]).
Conclusion: Our study revealed that superinfection was significantly related to the outcome, and that virus species impacts mortality. These findings plead for improving the tools used in daily practice to confirm certainty of superinfection and for a broader vaccination of individuals at risk of VRTIs.

Keywords: Paramyxoviridae, Pneumoviridae; influenza; mortality; outcome; respiratory tract infections; respiratory viruses.
 
Back
Top Bottom